UPC - Universe Pharmaceuticals INC

NasdaqGM - NasdaqGM Delayed price. Currency in USD
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
30/09/2022
30/09/2021
30/09/2020
30/09/2019
Total revenue
40,143
40,143
47,982
30,704
33,229
Cost of revenue
18,252
18,252
22,656
16,610
19,822
Gross profit
21,891
21,891
25,326
14,094
13,407
Operating expenses
Research development
7,644
7,644
5,466
583.125
618.437
Selling general and administrative
20,836
20,836
6,270
2,795
2,292
Total operating expenses
28,911
28,911
11,736
3,744
3,357
Operating income or loss
-7,019
-7,019
13,590
10,350
10,051
Interest expense
162.4
162.4
101.604
123.76
129.268
Total other income/expenses net
-802.302
-802.302
189.942
-125.633
-268.471
Income before tax
-7,984
-7,984
13,678
10,100
9,653
Income tax expense
752.419
752.419
2,359
2,542
2,102
Income from continuing operations
-8,737
-8,737
11,320
7,558
7,551
Net income
-8,737
-8,737
11,320
7,558
7,551
Net income available to common shareholders
-8,737
-8,737
11,320
7,558
7,551
Basic EPS
-
-
0.60
0.36
0.36
Diluted EPS
-
-
0.60
0.36
0.36
Basic average shares
-
-
18,981
21,000
21,000
Diluted average shares
-
-
18,981
21,000
21,000
EBITDA
-
-7,288
14,227
10,634
10,201